NCT06727669Recruiting
Longitudinal Cohort of Thrombosis and Hemostasis Diseases
Source: ClinicalTrials.gov · Last updated 11 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is a multicenter, prospective, longitudinal, observational cohort study to investigate thrombosis and hemostasis diseases in Chinese patients. This study will collect basic information, diagnostic and treatment information, as well as medical expense information of patients from medical records.The incidence and risk factors of thrombosis and hemostasis diseases, the treatment methods, prognosis and medical expenses of these patients in China will be analyzed. The study will use questionnaire to measure the exposure of patients, and prospectively follow-up to collect the prognosis information.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 3000 (estimated)
- First submitted
- 2 Dec 2024
- Start date
- 1 Nov 2024
- Primary completion date
- 31 Dec 2029
- Lead sponsor
- Peking University People's Hospital
- Diseases
- Haemophilia
- NCT number
- NCT06727669
What you commit to
- Study type: Observational
- Planned participants: 3000
- From 1 Nov 2024 to the primary completion date, 31 Dec 2029
- 5 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Long-term follow-up information for patients is not available for any reason, such as not being available or having a serious concomitant disease.
Other illness
- Patients with alcohol and drug addictions or mental illness affect their ability to comply with study requirements.
- According to the investigator, there are conditions that may endanger the patient's safety or affect his/her compliance.
Who the study is looking for
- Patients who were diagnosed as thrombosis and hemostasis diseases.
Sex: All · Accepts healthy volunteers
Sites (5)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Peking University Insititute of Hematology, Peking University People's Hospital Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
| Department of Hematology, Beijing Hospital Coordinator of this site? Confirm its status | Beijing | China | Not yet recruiting |
| Department of Hematology, Beijing Friendship Hospital, Capital Medical University Coordinator of this site? Confirm its status | Beijing | China | Not yet recruiting |
| Xinqiao Hospital, Army Military Medical University Coordinator of this site? Confirm its status | Chongqing | China | Not yet recruiting |
| The First Affiliated Hospital of Zhengzhou University Coordinator of this site? Confirm its status | Zhengzhou | China | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.